BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pellicano R, Franceschi F, Saracco G, Fagoonee S, Roccarina D, Gasbarrini A. Helicobacters and extragastric diseases. Helicobacter. 2009;14 Suppl 1:58-68. [PMID: 19712170 DOI: 10.1111/j.1523-5378.2009.00699.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 40] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Arslan MS, Ekiz F, Deveci M, Sahin M, Topaloglu O, Karbek B, Tutal E, Ginis Z, Cakal E, Ozbek M, Yuksel O, Delibasi T. The relationship between cytotoxin-associated gene A positive Helicobacter pylori infection and autoimmune thyroid disease. Endocr Res 2015;40:211-4. [PMID: 25970504 DOI: 10.3109/07435800.2015.1015727] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
2 Butenko T, Jeverica S, Orel R, Homan M. Antibacterial resistance and the success of tailored triple therapy in Helicobacter pylori strains isolated from Slovenian children. Helicobacter 2017;22. [PMID: 28653787 DOI: 10.1111/hel.12400] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.5] [Reference Citation Analysis]
3 Roubaud Baudron C, Franceschi F, Salles N, Gasbarrini A. Extragastric diseases and Helicobacter pylori. Helicobacter. 2013;18 Suppl 1:44-51. [PMID: 24011245 DOI: 10.1111/hel.12077] [Cited by in Crossref: 55] [Cited by in F6Publishing: 54] [Article Influence: 7.9] [Reference Citation Analysis]
4 Cen S, Jia J, Ge Y, Ma Y, Li X, Wei J, Bai Y, Wu X, Song J, Bi H, Wu B. A new antibacterial 3,5-dimethylorsellinic acid-based meroterpene from the marine fungus Aspergillus sp. CSYZ-1. Fitoterapia 2021;152:104908. [PMID: 33892126 DOI: 10.1016/j.fitote.2021.104908] [Reference Citation Analysis]
5 Di Simone N, Tersigni C, Cardaropoli S, Franceschi F, Di Nicuolo F, Castellani R, Bugli F, de Waure C, Cavaliere AF, Gasbarrini A, Sanguinetti M, Scambia G, Todros T. Helicobacter pylori infection contributes to placental impairment in preeclampsia: basic and clinical evidences. Helicobacter 2017;22:e12347. [DOI: 10.1111/hel.12347] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
6 Cizginer S, Ordulu Z, Kadayifci A. Approach to Helicobacter pylori infection in geriatric population. World J Gastrointest Pharmacol Ther 2014; 5(3): 139-147 [PMID: 25133042 DOI: 10.4292/wjgpt.v5.i3.139] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
7 Malfertheiner P, Selgrad M. Helicobacter pylori infection and current clinical areas of contention. Curr Opin Gastroenterol. 2010;26:618-623. [PMID: 20827182 DOI: 10.1097/mog.0b013e32833efede] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
8 [DOI: 10.1101/057356] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
9 Ribaldone DG, Fagoonee S, Colombini J, Saracco G, Astegiano M, Pellicano R. Helicobacter pylori infection and asthma: Is there a direct or an inverse association? A meta-analysis. World J Meta-Anal 2016; 4(3): 63-68 [DOI: 10.13105/wjma.v4.i3.63] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
10 Haghighi MA, Mobarez AM, Salmanian AH, Moazeni M, Zali MR, Sadeghi M, Amani J. In silico experiment with an-antigen-toll like receptor-5 agonist fusion construct for immunogenic application to Helicobacter pylori. Indian J Hum Genet 2013;19:43-53. [PMID: 23901192 DOI: 10.4103/0971-6866.112885] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 Pacifico L, Anania C, Osborn JF, Ferraro F, Chiesa C. Consequences of Helicobacter pylori infection in children. World J Gastroenterol 2010; 16(41): 5181-5194 [PMID: 21049552 DOI: 10.3748/wjg.v16.i41.5181] [Cited by in CrossRef: 52] [Cited by in F6Publishing: 40] [Article Influence: 4.7] [Reference Citation Analysis]
12 Ullah H, Di Minno A, Santarcangelo C, Khan H, Xiao J, Arciola CR, Daglia M. Vegetable Extracts and Nutrients Useful in the Recovery from Helicobacter pylori Infection: A Systematic Review on Clinical Trials. Molecules 2021;26:2272. [PMID: 33919894 DOI: 10.3390/molecules26082272] [Reference Citation Analysis]
13 Polyzos SA, Kountouras J, Zavos C, Deretzi G. The association between Helicobacter pylori infection and insulin resistance: a systematic review. Helicobacter 2011;16:79-88. [PMID: 21435084 DOI: 10.1111/j.1523-5378.2011.00822.x] [Cited by in Crossref: 123] [Cited by in F6Publishing: 130] [Article Influence: 12.3] [Reference Citation Analysis]
14 Yang F, Xu YL, Zhu RF. Helicobacter pylori infection and the risk of colorectal carcinoma: a systematic review and meta-analysis.Minerva Med. 2019;110:464-470. [PMID: 31368293 DOI: 10.23736/S0026-4806.19.05942-1] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 5.5] [Reference Citation Analysis]
15 Furuto Y, Kawamura M, Yamashita J, Yoshikawa T, Namikawa A, Isshiki R, Takahashi H, Shibuya Y. Relationship Between Helicobacter pylori Infection and Arteriosclerosis. Int J Gen Med 2021;14:1533-40. [PMID: 33935515 DOI: 10.2147/IJGM.S303071] [Reference Citation Analysis]
16 Fisher L, Fisher A, Smith PN. Helicobacter pylori Related Diseases and Osteoporotic Fractures (Narrative Review). J Clin Med 2020;9:E3253. [PMID: 33053671 DOI: 10.3390/jcm9103253] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Figura N, Franceschi F, Santucci A, Bernardini G, Gasbarrini G, Gasbarrini A. Extragastric manifestations of Helicobacter pylori infection. Helicobacter. 2010;15 Suppl 1:60-68. [PMID: 21054655 DOI: 10.1111/j.1523-5378.2010.00778.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 53] [Article Influence: 5.1] [Reference Citation Analysis]
18 Franceschi F, Tortora A, Gasbarrini G, Gasbarrini A. Helicobacter pylori and extragastric diseases. Helicobacter. 2014;19 Suppl 1:52-58. [PMID: 25167946 DOI: 10.1111/hel.12159] [Cited by in Crossref: 49] [Cited by in F6Publishing: 48] [Article Influence: 8.2] [Reference Citation Analysis]
19 Palframan SL, Kwok T, Gabriel K. Vacuolating cytotoxin A (VacA), a key toxin for Helicobacter pylori pathogenesis. Front Cell Infect Microbiol. 2012;2:92. [PMID: 22919683 DOI: 10.3389/fcimb.2012.00092] [Cited by in Crossref: 121] [Cited by in F6Publishing: 114] [Article Influence: 13.4] [Reference Citation Analysis]
20 Wahid SUH. Structural and functional characterization of the Helicobacter pylori cytidine 5'-monophosphate-pseudaminic acid synthase PseF: molecular insight into substrate recognition and catalysis mechanism. Adv Appl Bioinform Chem 2017;10:79-88. [PMID: 29062238 DOI: 10.2147/AABC.S139773] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Roesler BM, Rabelo-Gonçalves EM, Zeitune JM. Virulence Factors of Helicobacter pylori: A Review. Clin Med Insights Gastroenterol 2014;7:9-17. [PMID: 24833944 DOI: 10.4137/CGast.S13760] [Cited by in Crossref: 72] [Cited by in F6Publishing: 39] [Article Influence: 10.3] [Reference Citation Analysis]
22 Fu HW. Helicobacter pylori neutrophil-activating protein: From molecular pathogenesis to clinical applications. World J Gastroenterol 2014; 20(18): 5294-5301 [PMID: 24833859 DOI: 10.3748/wjg.v20.i18.5294] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
23 Campuzano-Maya G. Hematologic manifestations of Helicobacter pylori infection. World J Gastroenterol 2014; 20(36): 12818-12838 [PMID: 25278680 DOI: 10.3748/wjg.v20.i36.12818] [Cited by in CrossRef: 33] [Cited by in F6Publishing: 25] [Article Influence: 4.7] [Reference Citation Analysis]
24 Cohen D, Muhsen K. Association between Helicobacter pylori colonization and glycated hemoglobin levels: is this another reason to eradicate H. pylori in adulthood? J Infect Dis. 2012;205:1183-1185. [PMID: 22427675 DOI: 10.1093/infdis/jis110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.2] [Reference Citation Analysis]
25 Homan M, Šterbenc A, Kocjan BJ, Luzar B, Zidar N, Orel R, Poljak M. Prevalence of the Helicobacter pylori babA2 gene and correlation with the degree of gastritis in infected Slovenian children. Antonie Van Leeuwenhoek. 2014;106:637-645. [PMID: 25055876 DOI: 10.1007/s10482-014-0234-0] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
26 Kell DB, Kenny LC. A Dormant Microbial Component in the Development of Preeclampsia. Front Med (Lausanne) 2016;3:60. [PMID: 27965958 DOI: 10.3389/fmed.2016.00060] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 5.8] [Reference Citation Analysis]
27 Kariya S, Okano M, Nishizaki K. An association between Helicobacter pylori and upper respiratory tract disease: Fact or fiction? World J Gastroenterol 2014; 20(6): 1470-1484 [PMID: 24587622 DOI: 10.3748/wjg.v20.i6.1470] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 15] [Article Influence: 2.4] [Reference Citation Analysis]
28 Franceschi F, Di Simone N, D’Ippolito S, Castellani R, Di Nicuolo F, Gasbarrini G, Yamaoka Y, Todros T, Scambia G, Gasbarrini A. Antibodies anti-CagA cross-react with trophoblast cells: a risk factor for pre-eclampsia? Helicobacter. 2012;17:426-434. [PMID: 23066738 DOI: 10.1111/j.1523-5378.2012.00966.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 31] [Article Influence: 3.4] [Reference Citation Analysis]
29 Franceschi F, Brisinda D, Buccelletti F, Ruggieri MP, Gasbarrini A, Sorbo A, Marsiliani D, Venuti A, Fenici P, Gasbarrini G. Prevalence of virulent Helicobacter pylori strains in patients affected by idiopathic dysrhythmias. Intern Emerg Med. 2013;8:333-337. [PMID: 21562783 DOI: 10.1007/s11739-011-0621-8] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
30 Salah Ud-Din AIM, Roujeinikova A. Flagellin glycosylation with pseudaminic acid in Campylobacter and Helicobacter: prospects for development of novel therapeutics. Cell Mol Life Sci 2018;75:1163-78. [PMID: 29080090 DOI: 10.1007/s00018-017-2696-5] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 5.3] [Reference Citation Analysis]
31 Franchini M, Plebani M, Montagnana M, Veneri D, Lippi G. Pathogenesis, Laboratory, and Clinical Characteristics of Helicobacter pylori-Associated Immune Thrombocytopenic Purpura. Elsevier; 2010. pp. 131-44. [DOI: 10.1016/s0065-2423(10)52005-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
32 Marinoni C, Ribaldone DG, Rosso C, Astegiano M, Caviglia GP. Diagnosis of Helicobacter pylori infection: a look into molecular aspects of urea breath test. Minerva Biotecnol 2019;31. [DOI: 10.23736/s1120-4826.19.02555-2] [Cited by in Crossref: 9] [Article Influence: 4.5] [Reference Citation Analysis]
33 Astl J, Šterzl I. Activation of Helicobacter Pylori Causes Either Autoimmune Thyroid Diseases or Carcinogenesis in the Digestive Tract. Physiol Res. [DOI: 10.33549/physiolres.933118] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
34 Testerman TL, Semino-Mora C, Cann JA, Qiang B, Peña EA, Liu H, Olsen CH, Chen H, Appt SE, Kaplan JR, Register TC, Merrell DS, Dubois A. Both diet and Helicobacter pylori infection contribute to atherosclerosis in pre- and postmenopausal cynomolgus monkeys. PLoS One 2019;14:e0222001. [PMID: 31490998 DOI: 10.1371/journal.pone.0222001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Valenzano M, Bisio A, Grassi G. Helicobacter pylori and diabetes mellitus: a controversial relationship. Minerva Endocrinol 2019;44:301-9. [PMID: 31304727 DOI: 10.23736/S0391-1977.19.03021-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
36 Tersigni C, Franceschi F, Todros T, Cardaropoli S, Scambia G, Di Simone N. Insights into the Role of Helicobacter pylori Infection in Preeclampsia: From the Bench to the Bedside. Front Immunol 2014;5:484. [PMID: 25346732 DOI: 10.3389/fimmu.2014.00484] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
37 Chung GE, Heo NJ, Park MJ, Chung SJ, Kang HY, Kang SJ. Helicobacter pylori seropositivity in diabetic patients is associated with microalbuminuria. World J Gastroenterol 2013; 19(1): 97-102 [PMID: 23326169 DOI: 10.3748/wjg.v19.i1.97] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
38 Yeniova AÖ, Kucukazman M, Ata N, Dal K, Kefeli A, Başyiğit S, Aktaş B, Akın KO, Nazlıgül Y. The relationship between Helicobacter pylori and beta-2 microglobulin in humans. Biomed Res Int 2014;2014:615089. [PMID: 25243160 DOI: 10.1155/2014/615089] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
39 Pedullà M, Fierro V, Del Tufo E, Alfano R, Triassi M, Perrone L. Helicobacter pylori immunization and atopic dermatitis in South Italian children. United European Gastroenterol J. 2014;2:263-267. [PMID: 25083283 DOI: 10.1177/2050640614544314] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
40 Klesiewicz K, Karczewska E, Budak A, Marona H, Szkaradek N. Anti-Helicobacter pylori activity of some newly synthesized derivatives of xanthone. J Antibiot 2016;69:825-34. [DOI: 10.1038/ja.2016.36] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]